Walker Marlan D 4
4 · TherapeuticsMD, Inc. · Filed Apr 10, 2025
Insider Transaction Report
Form 4
Walker Marlan D
Chief Executive Officer
Transactions
- Purchase
Common Stock
2025-04-10$0.86/sh+1,167$1,000→ 73,149 total - Purchase
Common Stock
2025-04-09$0.87/sh+1,136$994→ 71,982 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices of $0.8741 through $0.88, inclusive. The reporting person undertakes to provide to TherapeuticsMD, Inc., any security holder of TherapeuticsMD, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth.